Literature DB >> 10415043

Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element.

S J Gobin1, M van Zutphen, A M Woltman, P J van den Elsen.   

Abstract

The IFN-stimulated response element (ISRE) is an important conserved cis-acting regulatory element in the promoter of MHC class I genes, but displays considerable locus-specific nucleotide variation. In this report, the putative ISREs of classical and nonclassical HLA class I genes were investigated for their contribution to MHC class I transactivation. It is shown that IFN-gamma induced MHC class I transactivation through the ISRE of HLA-A, HLA-B, HLA-C, and HLA-F. This is congruent with the binding of IFN regulatory factor-1 to the ISREs of these loci upon IFN-gamma treatment. Sp1 was shown to bind to the CG-rich sequences in the ISRE regions of HLA-B, HLA-C, and HLA-G. The putative E box 5' of the ISRE in most HLA-B alleles was shown to bind the upstream stimulatory factors (USF) 1 and 2. The Sp1 and USF binding sites did not influence IFN-gamma-induced transactivation. However, the USF binding site played a suppressive role in the constitutive expression of HLA-B. The locus-specific transcriptional control through the ISRE could be an important mechanism in the differential regulation of classical and nonclassical MHC class I expression, which determines adequate Ag presentation upon pathogenic challenge.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415043

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.

Authors:  L Gineau; P Luisi; E C Castelli; J Milet; D Courtin; N Cagnin; B Patillon; H Laayouni; P Moreau; E A Donadi; A Garcia; A Sabbagh
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

Review 2.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Authors:  Juergen Bukur; Felix Herrmann; Diana Handke; Christian Recktenwald; Barbara Seliger
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

4.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Identification and regulatory analysis of rainbow trout tapasin and tapasin-related genes.

Authors:  Eric D Landis; Yniv Palti; Jenefer Dekoning; Robert Drew; Ruth B Phillips; John D Hansen
Journal:  Immunogenetics       Date:  2006-01-27       Impact factor: 2.846

6.  Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Authors:  Veron Ramsuran; Pedro G Hernández-Sanchez; Colm O'hUigin; Gaurav Sharma; Niamh Spence; Danillo G Augusto; Xiaojiang Gao; Christian A García-Sepúlveda; Gurvinder Kaur; Narinder K Mehra; Mary Carrington
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

7.  The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association.

Authors:  Xiaoping Zhu; Junmin Peng; Raktima Raychowdhury; Atsushi Nakajima; Wayne I Lencer; Richard S Blumberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

8.  Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Authors:  Xindong Liu; Lilin Ye; Yu Bai; Habi Mojidi; Neil E Simister; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

10.  ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.

Authors:  Claire Y Oh; Martin G Klatt; Christopher Bourne; Tao Dao; Megan M Dacek; Elliott J Brea; Sung Soo Mun; Aaron Y Chang; Tatyana Korontsvit; David A Scheinberg
Journal:  Cancer Immunol Res       Date:  2019-09-20       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.